LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.59 | 21.74 | 2558 | 4492 | 0.5695 | 0.8588 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.59 | 21.74 | 6 | 4492 | 0.0013 | -0.1541 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.59 | 21.74 | 3019 | 4492 | 0.6721 | 0.8993 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 49.56 | 21.74 | 199 | 4838 | 0.0411 | 0.3284 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 49.56 | 21.74 | 2750 | 4838 | 0.5683 | 0.8602 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 49.56 | 21.74 | 11 | 4838 | 0.0023 | -0.0837 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 49.56 | 21.74 | 3285 | 4838 | 0.6789 | 0.9031 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 51.53 | 21.74 | 266 | 5150 | 0.0516 | 0.3737 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 51.53 | 21.74 | 2933 | 5150 | 0.5694 | 0.8622 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 51.53 | 21.74 | 11 | 5150 | 0.0021 | -0.0827 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 51.53 | 21.74 | 3521 | 5150 | 0.6836 | 0.9058 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 53.50 | 21.74 | 288 | 5425 | 0.0531 | 0.3833 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 53.50 | 21.74 | 3165 | 5425 | 0.5833 | 0.8691 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 53.50 | 21.74 | 8 | 5425 | 0.0015 | -0.1180 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 53.50 | 21.74 | 3699 | 5425 | 0.6817 | 0.9061 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 55.48 | 21.74 | 343 | 5768 | 0.0595 | 0.4086 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 55.48 | 21.74 | 3354 | 5768 | 0.5814 | 0.8697 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 55.48 | 21.74 | 16 | 5768 | 0.0028 | -0.0374 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 55.48 | 21.74 | 3939 | 5768 | 0.6828 | 0.9074 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 57.45 | 21.74 | 327 | 6023 | 0.0543 | 0.3967 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 57.45 | 21.74 | 3523 | 6023 | 0.5849 | 0.8721 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 57.45 | 21.74 | 10 | 6023 | 0.0017 | -0.0913 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 57.45 | 21.74 | 4198 | 6023 | 0.6969 | 0.9130 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 59.42 | 21.74 | 372 | 6125 | 0.0607 | 0.4176 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 59.42 | 21.74 | 3725 | 6125 | 0.6081 | 0.8814 | MN20160310_N01 | E22 |